News for Ardelyx, Inc. (ARDX)

**media[643746]**

**media[633082]**

**media[617621]**

You may be concerned about the recent declines in AI stocks such as NVDA.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday. Shares of Block, Inc. XYZ fell sharply in today's pre-ma...

New York-based Classover Holdings, Inc. (KIDZ) is up over 65 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Shares of Twilio Inc. TWLO rose sharply in pre-market trading after the company reported better-than-expected first-quarter financial results. Twilio reported ...

WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. ( ARDX), a biopharmaceutical company founded with a mission to discover, develop and commerci

Summary Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing innovative medicines for unmet medical needs, has announced a conference call sc

Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. ( ARDX), a biopharmaceutical company f

Ardelyx (ARDX) to announce Q1 2025 financial results on May 1, 2025. Conference call scheduled for 4:30 p.m. Eastern Time. Webcast replay available for 30

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Ardelyx Inc. (NASDAQ:ARDX) stands against other biotech penny stocks. Peter Marks’s departure from the FDA has left innovators concerned regarding the current state of the […]

Summary On April 10, 2025, Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing first-in-class medicines, announced the presentation of a pos

**media[592019]**

Award established to recognize leaders in the field of chronic kidney disease advocacy WALTHAM, Mass., March 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. ( AR

On February 24, 2025, David Mott, a Director at Ardelyx Inc (ARDX), purchased 77,729 shares of the company, as reported in a SEC Filing. Following this transact

On February 26, 2025, Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing innovative medicines, announced the approval of its New Drug Appli

PR NewswireSHANGHAI, Feb. 26, 2025 Bringing New Hope to Chinese Dialysis Patients with HyperphosphatemiaSHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fo